(REDWOOD CITY, CA, August 24, 2020)— Exo (pronounced “echo”), a pioneering health information and devices company, closed a $40 million Series B+ funding round that will fund research and product development on a revolutionary handheld medical device and cloud-based workflow software platform. Exo, a pioneering health information and devices company, secures $40M in Series B+ funding for research and product development on a revolutionary handheld medical device and cloud-based workflow software platform.
FORMER GOOGLE AND APPLE EXECUTIVE JOINS EXO
PRAKASH WILL AID THE STARTUP IN ITS MISSION TO PROVIDE FLEXIBLE HIGH-PERFORMANCE ULTRASOUND IMAGING THAT IS AFFORDABLE AND EASY TO USE
(REDWOOD CITY, CA, MAY 20, 2020)-— Exo (pronounced “Echo”) is pleased to announce the addition of Simon Prakash, who will serve as the company’s executive vice president of product engineering and report directly to CEO Sandeep Akkaraju. Simon joins at a time when Exo is disrupting the medical imaging space, bringing more than 24 years of technology leadership experience from Google, Apple, and most recently, AliveCor. Simon’s strong background in product development and innovation will be instrumental as he guides the development and engineering of imaging and data platforms at Exo.
EXO TECHNOLOGY TO HELP HEALTHCARE PROVIDERS DELIVER BETTER, FASTER AND MORE ACCURATE CARE
(REDWOOD CITY, CA, January 10, 2020) – Having recently secured $35M in Series B funding, Exo (pronounced “Echo”) Imaging is now accelerating its efforts to develop innovative technologies that will simplify, streamline and increase accessibility to medical imaging through the power of artificial intelligence (AI).
MEDICAL IMAGING STARTUP MAKES KEY ADDITIONS TO COMMERCIALIZATION AND PRODUCT TEAMS
(REDWOOD CITY, CA, November 5, 2019) - After securing $35 million in Series B capital funding this summer, Exo (pronounced “Echo”) Imaging continues to expand its team with proven leaders that have extensive ultrasound experience to lead the business from ideation to commercialization.
Exo Imaging Emerges from Stealth Mode with $35M Series B Financing Round to Advance Development of the Exo Ultrasound Platform
Exo Imaging, Inc., a company pioneering a high-performance ultrasound platform based on patented Piezoelectric Micromachined Ultrasonic Transducers (pMUT) technology and artificial intelligence (AI) for imaging and therapeutic applications, announced a $35M Series B financing round. The company was founded in 2015 and has raised nearly $50M to date. Intel Capital led the Series B. Other investors in Exo include: Applied Ventures, Bold Capital, Creative Ventures, Longevity Vision Fund, Magnetar Capital, Nautilus Venture Partners, OSF Healthcare, Rising Tide Fund, Sony Innovation Fund, and Wanxiang Healthcare Investments.